Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease

This publication has 70 references indexed in Scilit:

• Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangioles
  Gastroenterology, 2002
• Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
  Hepatology, 2002
• Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis
  Digestive and Liver Disease, 2002
• Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene
  Gastroenterology, 1996
• Pharmacology of Ursodeoxycholic Acid, an Enterohepatic Drug
  Scandinavian Journal of Gastroenterology, 1994
• Molecular aspects of membrane stabilization by ursodeoxycholate
  Gastroenterology, 1993
• A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
  New England Journal of Medicine, 1991
• Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial
  Gastroenterology, 1989
• IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?
  The Lancet, 1987
• Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up
  Digestive Diseases and Sciences, 1985